The World AMR Awareness Week webinar series begins next week covering the current capabilities and limitations of metagenomics and long-read sequencing, from detecting emerging and hard-to-culture pathogens to the persistent gap between a genomic result and an actionable clinical decision.

Explore the programme and register today to join live!

Science & Research

All parts of the recent Bundibugyo ebolavirus vaccine webinar series are now available for replay for free. Discover the expert presentations and examine the emerging data on the challenges presented by this ongoing outbreak.

Education

This course addresses the critical intersection between judicious antimicrobial use and effective infection control practices, emphasizing the importance of both aspects in combating antimicrobial resistance and reducing healthcare-associated infections. This course is part of the AMR Certificate programme but still has open seats.

Equip yourself with practical strategies for diagnosing and managing high-burden infectious diseases, particularly in resource-limited and tropical settings. Gain expertise through interactive, real-world clinical discussions led by national and international experts.

Explore the clinical and public health management of classical and emerging hepatitis viruses, including hepatitis A–E and viral haemorrhagic fevers such as yellow fever, dengue, and Crimean-Congo haemorrhagic fever. Persons interested in viral liver diseases will not want to miss this.

Congress & Events

ESCMID offers a variety of grants and awards for ESCMID Global abstract submitters ranging from 500 to 1,300 EUR to attend the congress. Be sure to check out the offerings and submit your abstract before the deadline on 18 November.

Guidelines & Journals

A new position statement developed jointly by ISAC and ESGS proposes standardised terminology for different mechanisms of methicillin resistance, aiming to improve the interpretation of susceptibility testing and support clearer communication in clinical practice and research.

Emily McDonald returns for another ‘Quarterly catch-up’ and is joined by Angela Huttner as co-host. Together, they review four recent randomised clinical trials, focusing on antibiotic treatment duration and different treatment approaches across a range of infections and patient populations.

The Bundibugyo Ebola outbreak in DRC, has reached 9,277 confirmed cases and 4,478 deaths. Kenya has eight cases linked to an imported index case, including three health workers, but no evidence of community transmission. Measles risk in the Americas is very high, with 55,792 cases and 77 deaths across 17 countries, mostly in Guatemala and Mexico. US transmission is rising, with 4,410 cases this year, nearly double the 2025 total. Dengue is surging widely: Chad has 213 confirmed cases and 7 deaths, Ecuador has exceeded its 2025 total amid a shift to DENV-3, Florida has 368 local cases and Italy 70. Europe’s record West Nile season (1,926 cases) is spreading north, with 59 Dutch cases and Belgium’s first local infections and deaths. Côte d’Ivoire reports 23 yellow fever cases and 11 deaths.

Hepatitis Delta in Spain: a nationwide prospective characterisation of active infection and liver disease severity